Asia
In Asia, Ibuprofen prices continued to rise in the fourth quarter of 2025. China, being a major producer, experienced steady demand both domestically and internationally. The growing need from pharmaceutical companies pushed suppliers to maintain higher prices. Limited raw material availability and production costs also contributed to the upward trend. Overall, the market showed that any changes in production or exports could quickly affect prices, reflecting the region’s strong influence on the global supply.
Europe
In Europe, Ibuprofen prices also increased during Q4’25. Countries like Germany faced challenges due to shortages and reliance on imports from Asia. Pharmacies reported frequent gaps in stock, and demand from hospitals and consumers kept pressure on the market. Supply chain delays and regional inefficiencies made it harder to stabilize prices. Overall, European markets were very sensitive to disruptions, which kept prices moving upwards throughout the quarter.
North America
In North America, Ibuprofen prices rose slightly in Q4’25, mainly due to higher demand in healthcare and retail pharmacies. The U.S. market saw efforts to lower medicine costs through new government initiatives, but most price adjustments focused on branded or new drugs rather than common over-the-counter painkillers. Supply from Asia influenced availability, and any global shortage affected local prices. Consumers still faced moderate increases, reflecting both demand and supply constraints.